A Metabolic Disease Posing Severe Pancreatic Risks Gets Its First FDA-Approved Therapy

Ionis Pharmaceuticals’ Tryngolza is now the first approved therapy for treating severe hypertriglyceridemia, a prevalent chronic metabolic disorder that can lead to acute pancreatitis. This drug is a key piece of Ionis’s pivot away from partnering its assets, and instead developing and commercializing them on its own. The post A Metabolic Disease Posing Severe Pancreatic…

Read More

KFF Poll Shows Three in Ten Adults Turn to Social Media or AI for Health Information, with Lower-Income Adults More Likely to Cite Cost and Access Barriers as a Reason — The Monitor

The latest KFF Tracking Poll on Health Information and Trust finds roughly three in ten adults report turning to social media (31%) or AI chatbots (29%) at least monthly for health information and advice. The top reasons people report turning to social media for health advice are wanting to hear from those with similar experiences…

Read More